Approval · Notice of Compliance 23481 · 2020
AMOXICILLIN: Notice of Compliance 23481
Issued April 20, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23481
- Date
- April 20, 2020
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Labelling Only
- Reason
- Updated labelling materials and licensing agreewment between two companies
- Canadian reference product
- APO-AMOXI (Apotex Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMOXICILLIN | 02401509 | Marketed |
Medicinal ingredients
- AMOXICILLIN TRIHYDRATE 573.394 MG per CAP